🔴 Exclusive webinar: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

Stock under ₹ 40 jumps 5% after securing orders worth $10 Mil for AI technology

Published 28-08-2024, 01:38 pm
Stock under ₹ 40 jumps 5% after securing orders worth $10 Mil for AI technology
IFIB
-

Shares of the company specializing in software development and AI services, increased by over 5 percent following the acquisition of orders valued at $10 million. These orders are for delivering AI services to hospitals in India and gas stations in the UAE.

Price Movement

The share price of Infibeam Avenues (NS:IFIB) Limited jumped by over 5 percent, reaching an intra-day high of Rs.32.37 per share, up from its previous close of Rs.30.79. Over the past year, the share has delivered a return of more than 120 percent.

Is Infibeam Avenues a buy or sell? What is its Fair Value? What are the company's health parameters? What are the positive and negative factors driving the company -- ProTips? Know all the answers on the company's overview page here.

What is the news

Phronetic.AI, a division of Infibeam Avenues Limited, has achieved a major milestone by securing two significant contracts for its Theia Vision AI technology. The contracts, valued at $1 million annually each, span five years with options for extension.

The first contract involves integrating Theia Vision AI’s ‘AI Facility Manager’ into five leading hospitals in India, where it will enhance diagnostics, real-time patient monitoring, and resource allocation.

The second contract, with a UAE-based gas station chain, will deploy the same AI technology to improve security, customer service, and operational efficiency at their stations, focusing on real-time threat detection and automated transaction monitoring.

These contracts highlight Phronetic.AI’s expanding influence and its technology’s transformative potential in healthcare and the energy sector.

Recent Strategic Developments

In Q1, the company added 2,30,022 new merchants, averaging over 2,550 daily. BillAvenue (Bills Payment Platform of Infibeam) saw an 87 percent increase in transaction value quarter-on-quarter. ResAvenue (Hospitality Platform) delivered 4,67,248 hospital room nights, generating over Rs.310 crores.

Future Outlook

Phronetic.AI has submitted a patent application to the US Patent Office for AI-driven activity-based management.

Additionally, Infibeam intends to acquire a majority stake in Rediff.com to merge digital payments with cloud email storage and content distribution, aiming to enhance engagement and explore new revenue opportunities with Rediff’s 55 million monthly visitors.

Financials

For the quarter ending June 30, 2024, Infibeam Avenues Limited reported consolidated revenue of Rs.753 crore, reflecting an increase of 1.48 percent from Rs.742 crore in the same quarter the previous year. The company’s net profit for Q1 FY25 rose to Rs.70 crore, marking a substantial 180 percent increase compared to Rs.25 crore in Q1 FY24.

Company Profile

Infibeam Avenues provides digital payment solutions and enterprise software platforms to businesses and governments across various industries. Its digital payment services are offered under the brand CCAvenue, while its enterprise software solutions are branded as BuildaBazaar.

Written by – Siddesh S Raskar

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Stock under ₹ 40 jumps 5% after securing orders worth $10 Mil for AI technology appeared first on Trade Brains.

Read More

To understand more about InvestingPro, watch this video: https://www.youtube.com/watch?v=_WfQcN5vjI

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.